BL Pharmtech Corp. Logo

BL Pharmtech Corp.

Researches, develops, and sells health foods, supplements, and pharmaceuticals.

065170 | KO

Overview

Corporate Details

ISIN(s):
KR7065170003
LEI:
Country:
South Korea
Address:
경기도 용인시 수지구 신수로 767 134호(동천동, 분당수지유타워 지식산업센터), 용인시

Description

BL Pharmtech Corp. is a healthcare company that manufactures, distributes, and sells health functional foods, dietary supplements, and nutraceuticals. The company's portfolio also includes cosmetics, food additives, and pharmaceuticals. A significant part of its operations is dedicated to biotechnology and bio-pharmaceutical research and development. Through its Daedeok Research Institute and in collaboration with subsidiaries BL Melanys and BL Science, the company partners with academic institutions, including KAIST and Columbia University Medical Center, to advance its research initiatives.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-31 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean HTML 15.3 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1.2 MB
2025-07-30 00:00
증권발행결과(자율공시) (제21회차 CB)
Korean HTML 5.6 KB
2025-07-28 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean HTML 12.8 KB
2025-07-22 00:00
주요사항보고서(전환사채권발행결정)
Korean HTML 56.8 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean HTML 1.2 MB
2025-03-31 00:00
정기주주총회결과
Korean HTML 17.5 KB
2025-03-28 00:00
전환가액의조정 (제19회차)
Korean HTML 13.1 KB
2025-03-21 00:00
감사보고서제출
Korean HTML 26.6 KB
2025-03-21 00:00
사업보고서 (2024.12)
Korean HTML 2.0 MB
2025-03-14 00:00
주주총회소집결의
Korean HTML 6.6 KB
2025-03-14 00:00
주주총회소집공고
Korean HTML 187.3 KB
2025-03-12 00:00
단일판매ㆍ공급계약체결
Korean HTML 9.6 KB
2025-02-27 00:00
전환가액의조정
Korean HTML 21.1 KB
2025-02-27 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 103.9 KB

Automate Your Workflow. Get a real-time feed of all BL Pharmtech Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BL Pharmtech Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BL Pharmtech Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.